Research on the beta glucan ingredient was presented at the Experimental Biology 2011 conference.
Wellmune WGP may be effective in reducing symptoms of ragweed allergy, according to new research presented by Biothera (Eagan, MN) at the recent Experimental Biology 2011 conference.
Allergies to ragweed pollen affect an estimated 36 million Americans, according to Biothera, and the symptoms aren’t friendly: nasal congestion, sneezing, difficulty in breathing, and itchy eyes.
In a placebo-controlled, double blinded study, 48 healthy subjects were assigned to 250 mg of Wellmune WGP or placebo daily for four weeks. Subjects were located in an area of southeast Ohio where ragweed pollen counts are deemed high.
After four weeks of supplementation, researchers concluded that Wellmune WGP was associated with statistically significant reductions in symptoms and severity of general ragweed allergy and nasal- and eye-specific allergy symptoms.